Abstract:OBJECTIVE:To explore gene expression of NANOG in T-cell acute lymphoblastic leukemia (T-ALL) cell lines and the effects of NANOG gene down-regulation on apoptosis of leukemia cells. METHODS:Real-time PCR (RT-PCR) and Western blot were used to detect the expression level of NANOG gene and protein in MOLT-4, CCRF-HSB2 and Jurkat cells. To test the efficiency of RNA interference, MOLT-4 cells were firstly infected by lentiviral vectors, which were successfully constructed with NANOG specific shRNA. NANOG expression levels were subsequently re-evaluated by RT-PCR and Western blot. The percentages of early apoptotic cells (Annexin V⁺/7-AAD⁻) and late apoptotic cells (Annexin V⁺/7-AAD⁺) were analyzed by flow cytometry. The expression of apoptosis-related genes was also detected. RESULTS:Both NANOG gene and protein expression was positive in MOLT-4 and CCRF-HSB2 cells. The lentiviral vectors pLB-shNANOG-1, pLB-shNANOG-2, and pLB-sh control were successfully constructed, as evidenced by the viral titers (1.83-3.12)× 10⁸ IU/ml. The experimental data on infection of MOLT-4 cells with such lentiviral vectors revealed that both shRNA interfering sequences (shNANOG-1 and shNANOG-2) could stably down-regulate NANOG gene and protein expressions. The percentages of early apoptotic cells in groups of shNANOG-1[(8.06 ± 1.61)%]and shNANOG-2[(5.67 ± 1.59)%]were significantly increased as compared to that of MOLT-4 group[(1.13 ± 0.40)%]or sh-control [(1.15±0.49)%](P<0.05). However, no statistical difference among them was observed for late apoptotic cells (P>0.05). The gene expression of TP53, PMAIP1, and CASP9 of either shNANOG-1 or shNANOG-2 group was augmented as compared to that of MOLT-4 group or sh-control (P<0.05). Reversely, a significant down-regulation of Bcl-2 gene expression was observed (P<0.05). CONCLUSION:NANOG can be expressed in various human T-ALL cell lines. Down-regulation of NANOG can trigger leukemia cellular apoptosis through mitochondria-dependent apoptosis pathway.

MYCN gene silence enhance TRAIL induced apoptosis in MYCN amplified NB cell line SK-N-BE(2)

Induction of Apoptosis in Neuroblastoma Cell Line SK-N-BE(2) by Modified Expression of MYCN Gene

Suppression of MYCN Gene Expression by Sirna Induced Apoptosis to Neuroblastoma Cells

Up-regulated Expression of MYCN Gene Induce Apoptosis and Chemo-Sensitivity of Neuroblastoma Cell

Decreased Expression of N-myc Protein Inhibits Cell Proliferation and Migration of Neuroblastoma Cell Line SK-N-BE (2)

Linking of N-Myc to Death Receptor Machinery in Neuroblastoma Cells

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

[Effects of NANOG Gene Down-Regulation on the Apoptosis of T-cell Acute Lymphoblastic Leukemia Cells].

Cytokine-induced Killer Cells/natural Killer Cells Combined with Anti-Gd2 Monoclonal Antibody Increase Cell Death Rate in Neuroblastoma SK-N-SH Cells

Silencing of the MYCN Gene by Sirna Delivered by Folate Receptor-Targeted Liposomes in LA-N-5 Cells

RNAi Silencing of the MEKK3 Gene Promotes TRAIL-induced Apoptosis in MCF-7 Cells and Suppresses the Transcriptional Activity of NF-κB.

Enhancing TRAIL-induced apoptosis by Bcl-XL siRNA

Targeted Knockdown Of Bcl2 In Tumor Cells Using A Synthetic Trail 3 '-Utr Microrna

Sirna‐mediated BCL‐2 AND BCL‐XL GENE SILENCING SENSITIZES HUMAN HEPATOBLASTOMA CELLS TO CHEMOTHERAPEUTIC DRUGS

Novel Molecular Regulators of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail)-Induced Apoptosis in NSCLC Cells

Effect of DDP and VP16 on the expression of Trk family in neuroblastoma cells and its clinic significance

Inhibition of Autophagy Potentiates the Efficacy of Gli Inhibitor GANT-61 in MYCN-amplified Neuroblastoma Cells

A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins

Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in <i>MYCN</i>-amplified neuroblastoma

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63

Effects of silencing NOTCH1 gene by eukaryotic vector in multiple myeloma RPMI 8226 cell line